Literature DB >> 26444888

A Brief Description of the Operation of the DoD Serum Repository.

Christopher L Perdue1, Angelia A Eick-Cost1, Mark V Rubertone1.   

Abstract

Beginning in 1985, the United States military has consistently maintained repositories of frozen human serum for force health protection reasons. The separate repositories created by the Army, Navy, and Air Force during the startup of their human immunodeficiency virus (HIV) screening programs were fully combined by 1996, along with the Defense Medical Surveillance System, to form the DoD Serum Repository (DoDSR). Currently comprised of 450,000 square feet of storage space at a constant -30 degrees Celsius, the DoDSR, operated by the Armed Forces Health Surveillance Center (AFHSC), receives approximately 2 million new serum specimens per year as a result of current HIV screening programs and pre- and post-deployment serum collection. Following initial testing for HIV when required, each specimen remains frozen until needed for clinical testing or a public health study, and its physical location is carefully tracked. Certain militarily-relevant research studies occur, though the serum from a specific individual is never allowed to be fully exhausted. AFHSC maintains careful control over the repository, utilizing a scientific review board to determine which requests for serum will be granted. As of 2012, only 0.42% of all of the frozen specimens in the DoDSR had been thawed for any type of use. The addition of new specimen processing capacity and significant changes to policy would be required if more of the specimens were to be used to answer relevant epidemiological, operational, or medical research questions. Reprint &
Copyright © 2015 Association of Military Surgeons of the U.S.

Entities:  

Mesh:

Year:  2015        PMID: 26444888     DOI: 10.7205/MILMED-D-14-00739

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  10 in total

1.  Timing of Elevations of Autoantibody Isotypes Prior to Diagnosis of Rheumatoid Arthritis.

Authors:  Lindsay B Kelmenson; Brandie D Wagner; Bryan K McNair; Ashley Frazer-Abel; M Kristen Demoruelle; Dylan T Bergstedt; Marie L Feser; Laura K Moss; Mark C Parish; Elizabeth A Mewshaw; Ted R Mikuls; Jess D Edison; V Michael Holers; Kevin D Deane
Journal:  Arthritis Rheumatol       Date:  2019-12-26       Impact factor: 10.995

2.  Autoantibodies to Malondialdehyde-Acetaldehyde Are Detected Prior to Rheumatoid Arthritis Diagnosis and After Other Disease Specific Autoantibodies.

Authors:  Ted R Mikuls; Jess Edison; Elizabeth Meeshaw; Harlan Sayles; Bryant R England; Michael J Duryee; Carlos D Hunter; Lindsay B Kelmenson; Laura Kay Moss; Marie L Feser; Brandie Wagner; Mark C Parish; Kevin D Deane; Geoffrey M Thiele
Journal:  Arthritis Rheumatol       Date:  2020-10-15       Impact factor: 10.995

3.  Integrative Network Analysis Linking Clinical Outcomes With Environmental Exposures and Molecular Variations in Service Personnel Deployed to Balad and Bagram.

Authors:  Juilee Thakar; Thomas H Thatcher; Matthew Ryan Smith; Collynn F Woeller; Douglas I Walker; Mark J Utell; Philip K Hopke; Timothy M Mallon; Pamela L Krahl; Patricia Rohrbeck; Young-Mi Go; Dean P Jones; Karan Uppal
Journal:  J Occup Environ Med       Date:  2019-12       Impact factor: 2.162

4.  A nested case-control study of serum polychlorinated biphenyls and papillary thyroid cancer risk among U.S. military service members.

Authors:  Haoran Zhuo; Huang Huang; Andreas Sjodin; Lan Jin; Shuangge Ma; Hristina Denic-Roberts; Joshua L Warren; Richard Jones; Mark Davis; Peiyuan Sun; Herbert Yu; Mary H Ward; Robert Udelsman; Yawei Zhang; Jennifer A Rusiecki
Journal:  Environ Res       Date:  2022-05-02       Impact factor: 8.431

5.  Deployment-Associated Exposure Surveillance With High-Resolution Metabolomics.

Authors:  Douglas I Walker; Col Timothy M Mallon; Philip K Hopke; Karan Uppal; Young-Mi Go; Patricia Rohrbeck; Kurt D Pennell; Dean P Jones
Journal:  J Occup Environ Med       Date:  2016-08       Impact factor: 2.162

6.  The Deepwater Horizon Oil Spill Coast Guard Cohort study.

Authors:  Jennifer Rusiecki; Melannie Alexander; Erica G Schwartz; Li Wang; Laura Weems; John Barrett; Kate Christenbury; David Johndrow; Renée H Funk; Lawrence S Engel
Journal:  Occup Environ Med       Date:  2017-09-12       Impact factor: 4.402

7.  Challenges to the performance of current HIV diagnostic assays and the need for centralized specimen archives: a review of the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA) repository.

Authors:  Shelley N Facente; Michael P Busch; Eduard Grebe; Christopher D Pilcher; Alex Welte; Brian Rice; Gary Murphy
Journal:  Gates Open Res       Date:  2019-07-23

8.  Live Oral Adenovirus Type 4 and Type 7 Vaccine Induces Durable Antibody Response.

Authors:  Natalie D Collins; Anima Adhikari; Yu Yang; Robert A Kuschner; Nicos Karasavvas; Leonard N Binn; Shannon D Walls; Paul C F Graf; Christopher A Myers; Richard G Jarman; Jun Hang
Journal:  Vaccines (Basel)       Date:  2020-07-23

Review 9.  Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit.

Authors:  Yoram Vodovotz; Neal Barnard; Frank B Hu; John Jakicic; Liana Lianov; David Loveland; Daniel Buysse; Eva Szigethy; Toren Finkel; Gwendolyn Sowa; Paul Verschure; Kim Williams; Eduardo Sanchez; Wayne Dysinger; Victoria Maizes; Caesar Junker; Edward Phillips; David Katz; Stacey Drant; Richard J Jackson; Leonardo Trasande; Steven Woolf; Marcel Salive; Jeannette South-Paul; Sarah L States; Loren Roth; Gary Fraser; Ron Stout; Michael D Parkinson
Journal:  Front Med (Lausanne)       Date:  2020-12-22

10.  Antibodies to Citrullinated Protein Antigens, Rheumatoid Factor Isotypes and the Shared Epitope and the Near-Term Development of Clinically-Apparent Rheumatoid Arthritis.

Authors:  Dylan T Bergstedt; Wyatt J Tarter; Ryan A Peterson; Marie L Feser; Mark C Parish; Christopher C Striebich; M Kristen Demoruelle; LauraKay Moss; Elizabeth A Bemis; Jill M Norris; V Michael Holers; Jess D Edison; Geoffrey M Thiele; Ted R Mikuls; Kevin D Deane
Journal:  Front Immunol       Date:  2022-06-22       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.